Texas ChE researchers recently published preclinical test results showing the use of antibodies in mice and baboons was successful in providing short-term immunity and an accelerated recovery from pertussis, also known as whooping cough. The findings, which were published in a paper on Dec. 2 in Science Translational Medicine, will help advance the treatment … Read the rest »
Posts Tagged ‘Synthetic Biologics’
Maynard Group’s Preclinical Findings Bring Whooping Cough Treatment Closer to Human Trials
Finding A Better Way To Fight Whooping Cough
Abby Bassett was only four weeks old when what seemed to be a mild cold turned into a much harsher reality.
The newborn was diagnosed with pertussis, or whooping cough, a disease that claims the lives of 195,000 children across the globe annually.
Now, Jennifer Maynard, an associate professor in the McKetta Department … Read the rest »
Maynard Teams Up With Synthetic Biologics To Fight Whooping Cough
Associate Professor Jennifer Maynard, the Laurence E. McMakin, Jr. Centennial Faculty Fellow, has teamed up with biotech company Synthetic Biologics, Inc. to develop a monoclonal antibody (mAb) therapy for the treatment of pertussis, commonly known as whooping cough.
Whooping cough causes an estimated 294,000 deaths annually worldwide, primarily among young, unvaccinated children. Recent reports … Read the rest »